Condition
Sensory Testing
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Unknown1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06725615Not ApplicableWithdrawnPrimary
Effect of Umami Exposure on MSG Induced-satiation
NCT07438028Not ApplicableNot Yet RecruitingPrimary
Energy Reduction and Umami
NCT07317752Not Yet Recruiting
Incidence of Dysgeusia in Breast Cancer Patients Undergoing Chemotherapy
NCT03787394Not ApplicableUnknownPrimary
Sensory and Hedonic Effects of FAAA-conjugates Added to Food Products
Showing all 4 trials